Detalhe da pesquisa
1.
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Ann Hematol
; 103(1): 185-198, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851072
2.
Cost-effectiveness of first-line vs third-line ibrutinib in patients with untreated chronic lymphocytic leukemia.
Blood
; 136(17): 1946-1955, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32518952
3.
Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib.
J Infect Chemother
; 27(12): 1700-1705, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34389223
4.
The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN).
Transpl Infect Dis
; 21(2): e13059, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30737868
5.
Infusion reactions are common after high-dose carmustine in BEAM chemotherapy and are not reduced by lengthening the time of administration.
Support Care Cancer
; 25(1): 205-208, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27614867
6.
Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation.
Ann Hematol
; 98(1): 237-240, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30027436
7.
Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy.
Bone Marrow Transplant
; 59(2): 211-216, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37973893
8.
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma.
Blood Adv
; 7(5): 801-810, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342852
9.
Impact of Memory T Cells on SARS-COV-2 Vaccine Response in Hematopoietic Stem Cell Transplant.
bioRxiv
; 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961434
10.
Peripheral Blood Involvement at Staging in Patients With Aggressive Peripheral T-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 22(9): 680-689, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568635
11.
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma.
Leuk Lymphoma
; 63(4): 821-833, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865586
12.
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.
EJHaem
; 3(2): 394-405, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846031
13.
Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.
EJHaem
; 3(1): 139-153, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846221
14.
Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13.
Rheumatology (Oxford)
; 50(5): 824-9, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21149242
15.
Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusion.
Am J Health Syst Pharm
; 78(12): 1112-1117, 2021 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617630
16.
Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma.
Leuk Lymphoma
; 61(14): 3387-3394, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32835553
17.
Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas.
Leuk Lymphoma
; 61(12): 2955-2961, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32643494
18.
Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib.
Clin Lymphoma Myeloma Leuk
; 20(11): 720-723, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727701
19.
Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience.
Leuk Lymphoma
; 61(9): 2180-2190, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32362171
20.
Transplantation in the Treatment of Primary Cutaneous Aggressive Epidermotropic Cytotoxic CD8-Positive T-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 18(1): e85-e93, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29223388